These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38705089)
1. Assessment of tumor-infiltrating lymphocytes in head and neck cancer: Clinical scenarios. Almangush A; Mäkitie AA; Leivo I Oral Oncol; 2024 Jun; 153():106829. PubMed ID: 38705089 [No Abstract] [Full Text] [Related]
2. TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)? De Meulenaere A; Vermassen T; Aspeslagh S; Vandecasteele K; Rottey S; Ferdinande L Head Neck Pathol; 2017 Sep; 11(3):354-363. PubMed ID: 28032290 [TBL] [Abstract][Full Text] [Related]
3. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Uppaluri R; Dunn GP; Lewis JS Cancer Immun; 2008 Dec; 8():16. PubMed ID: 19053167 [TBL] [Abstract][Full Text] [Related]
4. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice. Almangush A; Leivo I; Mäkitie AA Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615 [No Abstract] [Full Text] [Related]
5. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma. Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394 [TBL] [Abstract][Full Text] [Related]
6. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors. de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916 [TBL] [Abstract][Full Text] [Related]
7. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas. Sanchez-Canteli M; Granda-Díaz R; Del Rio-Ibisate N; Allonca E; López-Alvarez F; Agorreta J; Garmendia I; Montuenga LM; García-Pedrero JM; Rodrigo JP Cancer Immunol Immunother; 2020 Oct; 69(10):2089-2100. PubMed ID: 32448984 [TBL] [Abstract][Full Text] [Related]
8. Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer. Lei Y; Xie Y; Tan YS; Prince ME; Moyer JS; Nör J; Wolf GT Oral Oncol; 2016 Oct; 61():159-65. PubMed ID: 27553942 [TBL] [Abstract][Full Text] [Related]
9. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143 [TBL] [Abstract][Full Text] [Related]
10. Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer. Chimote AA; Hajdu P; Sfyris AM; Gleich BN; Wise-Draper T; Casper KA; Conforti L Cancer Res; 2017 Jan; 77(1):53-61. PubMed ID: 27815390 [TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT; Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675 [TBL] [Abstract][Full Text] [Related]
12. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843 [TBL] [Abstract][Full Text] [Related]
13. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas. Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367 [TBL] [Abstract][Full Text] [Related]
14. Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8 Sivars L; Landin D; Grün N; Vlastos A; Marklund L; Nordemar S; Ramqvist T; Munck-Wikland E; Näsman A; Dalianis T Anticancer Res; 2017 Feb; 37(2):665-673. PubMed ID: 28179315 [TBL] [Abstract][Full Text] [Related]
15. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685 [TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell receptor variability in fresh tumor-infiltrating lymphocytes from human head and neck cancer. Chikamatsu K; Eura M; Nakano K; Kanzaki Y; Matsuoka H; Masuyama K; Ishikawa T Jpn J Cancer Res; 1994 Jun; 85(6):626-32. PubMed ID: 8063616 [TBL] [Abstract][Full Text] [Related]
17. Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer. Chikamatsu K; Eura M; Nakano K; Masuyama K; Ishikawa T Jpn J Cancer Res; 1995 May; 86(5):477-83. PubMed ID: 7790320 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488 [TBL] [Abstract][Full Text] [Related]
19. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes. De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753 [TBL] [Abstract][Full Text] [Related]
20. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Vetto JT; Lum S; Morris A; Sicotte M; Davis J; Lemon M; Weinberg A Am J Surg; 1997 Sep; 174(3):258-65. PubMed ID: 9324133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]